IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a

Authors:
Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY, Zou Y, Bao S, Hanada N, Saso H, Kobayashi R and Hung MC
In:
Source: Cell
Publication Date: (2004)
Issue: 117(2): 225-237
Research Area:
Cancer Research/Cell Biology
Experiment
FOXO3a was knocked down by siRNA in the human breast carcinoma cell line MDA-MB-453 and in the human ovarian adenocarcinoma cell line SK-OV-3 ip1. The FOXO3a knock-down cells were tested in a breast cancer mouse model. They were injected into the mammary fat pads of nude mice and tumor growth was measured. Knock-down of FOXO3a increased tumor growth, showing the suppression effect of FOXO3a on tumorigenesis.
Abstract
Nuclear exclusion of the forkhead transcription factor FOXO3a by protein kinase Akt contributes to cell survival. We investigated the pathological relationship between phosphoylated-Akt (Akt-p) and FOXO3a in primary tumors. Surprisingly, FOXO3a was found to be excluded from the nuclei of some tumors lacking Akt-p, suggesting an Akt-independent mechanism of regulating FOXO3a localization. We provide evidence for such a mechanism by showing that IkappaB kinase (IKK) physically interacts with, phosphorylates, and inhibits FOXO3a independent of Akt and causes proteolysis of FOXO3a via the Ub-dependent proteasome pathway. Cytoplasmic FOXO3a correlates with expression of IKKbeta or Akt-p in many tumors and associates with poor survival in breast cancer. Further, constitutive expression of IKKbeta promotes cell proliferation and tumorigenesis that can be overridden by FOXO3a. These results suggest the negative regulation of FOXO factors by IKK as a key mechanism for promoting cell growth and tumorigenesis.